After publication of the original article [1], we were notified that family names have been exchanged with the first names for all authors. Below the name are tagged correctly.
View Article and Find Full Text PDFBackground: In France, the incidence of severe imported malaria cases increased since early 2000. Artesunate was available (temporarily use authorization) since mid-2011 in France and commonly used for severe malaria since early 2013. Thus, the study objectives were to describe the patients with severe imported malaria admitted in intensive care unit (ICU) and assess the changes in clinical presentation and outcomes before and after this date.
View Article and Find Full Text PDF